M
Minerva Surgical
Delivering next generation products for the treatment of abnormal uterine bleeding, a condition that affects almost 1 in 5 women
About Minerva Surgical
Minerva Surgical specializes in providing a one-time treatment solution for women suffering from heavy menstrual bleeding. The company's core product, the Minerva Endometrial Ablation System, is designed to significantly reduce or eliminate heavy periods, with a reported 93% success rate in reducing menstrual flow to normal or less levels. The treatment is quick, averaging 3-4 minutes, and has high patient satisfaction, with 95% of patients willing to recommend the procedure to others.
Read full description
Minerva Surgical primarily serves women experiencing abnormal uterine bleeding (AUB) and collaborates closely with healthcare professionals, including gynecologists and obstetricians. The company operates within the medical device market, focusing on women's health. Its business model revolves around the sale and distribution of its proprietary endometrial ablation system to healthcare providers, who then offer the treatment to patients.
Revenue is generated through the direct sale of the Minerva Endometrial Ablation System to medical facilities and practitioners. The company also benefits from ongoing relationships with healthcare providers who recommend and perform the procedure.
Minerva Surgical's market presence is bolstered by FDA approval and endorsements from reputable medical organizations such as the American College of Obstetricians and Gynecologists and the American Association of Gynecologic Laparoscopists.
At a glance
- Founded
- 2008
- Headquarters
- Cupertino, United States
- Listing
- IPO 2021
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Latest news
Press, funding announcements and product moves mentioning Minerva Surgical.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Versant Ventures
Novo Ventures
Series B and later1 investor entered at this stage
Armentum Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Minerva Surgical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Minerva Surgical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.